Comparison of effects of valproate and trans-2-en-valproate on different forms of epileptiform activity in rat hippocampal and temporal cortex slices

被引:24
作者
Sokolova, S
Schmitz, D
Zhang, CL
Löscher, W
Heinemann, U
机构
[1] Humboldt Univ, Inst Physiol Charite, Abt Neurophysiol, D-10117 Berlin, Germany
[2] Tierarztlichen Hsch Hannover, Inst Pharmakol Toxikol & Pharm, Hannover, Germany
关键词
epileptiform activity; valproate; trans-2-en-valproate; valproate-sensitive electrodes;
D O I
10.1111/j.1528-1157.1998.tb01369.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: Reducing the extracellular magnesium or calcium or increasing the extracellular potassium induces different patterns of epileptiform activity in the hippocampus and the entorhinal cortex. Although in the low Ca2+ and K+ models, seizure-like events (SLEs) develop in area. CA1 of the hippocampus, only short recurrent discharges develop in the low Mg2+ model. In contrast, in low Mg2+, SLEs and late recurrent discharges (LRDs) are observed in the entorhinal cortex. Methods: We compared the effects of valproate (VPA) and its major metabolite, trans-2-en-VPA (TVPA), on all these different model activities using extracellular field potential measurements. We also investigated the equilibration time course of VPA in the slice by using VPA-sensitive microelectrodes. Results: Both drugs reversibly blocked most forms of epileptiform activity. The only exception was the LRDs in the entorhinal cortex. In paired experiments, TVPA appeared to be more effective than VPA bath applied with the same concentration to the same slice. With our measurements of the VPA concentrations in slices, we showed that the concentrations used were close to therapeutic drug levels. Conclusions: If TVPA stands the toxicological tests, it might be a useful alternative in the treatment of seizures.
引用
收藏
页码:251 / 258
页数:8
相关论文
共 41 条
[21]  
LESCHINGER A, 1993, EXP BRAIN RES, V96, P230
[22]   TRANS-2-EN-VALPROATE - REEVALUATION OF ITS ANTICONVULSANT EFFICACY IN STANDARDIZED SEIZURE MODELS IN MICE, RATS AND DOGS [J].
LOSCHER, W ;
HONACK, D ;
NOLTING, B ;
FASSBENDER, CP .
EPILEPSY RESEARCH, 1991, 9 (03) :195-210
[23]   EFFECTS OF VALPROATE AND E-2-EN-VALPROATE ON FUNCTIONAL AND MORPHOLOGICAL PARAMETERS OF RAT-LIVER .1. BIOCHEMICAL, HISTOPATHOLOGICAL AND PHARMACOKINETIC STUDIES [J].
LOSCHER, W ;
WAHNSCHAFFE, U ;
HONACK, D ;
WITTFOHT, W ;
NAU, H .
EPILEPSY RESEARCH, 1992, 13 (03) :187-198
[24]  
LOSCHER W, 1992, PHARM WEEKBLAD, V14, P139
[25]   EFFECTS OF VALPROATE AND E-2-EN-VALPROATE ON FUNCTIONAL AND MORPHOLOGICAL PARAMETERS OF RAT-LIVER .2. INFLUENCE OF PHENOBARBITAL COMEDICATION [J].
LOSCHER, W ;
NAU, H ;
WAHNSCHAFFE, U ;
HONACK, D ;
RUNDFELDT, C ;
WITTFOHT, W ;
BOJIC, U .
EPILEPSY RESEARCH, 1993, 15 (02) :113-131
[26]   EFFECTS OF THE ANTIEPILEPTIC DRUG VALPROATE ON METABOLISM AND FUNCTION OF INHIBITORY AND EXCITATORY AMINO-ACIDS IN THE BRAIN [J].
LOSCHER, W .
NEUROCHEMICAL RESEARCH, 1993, 18 (04) :485-502
[27]  
LOSCHER W, 1989, J PHARMACOL EXP THER, V250, P1067
[28]   SIMULTANEOUS AND CONTINUOUS MEASUREMENT OF FREE CONCENTRATION OF VALPROATE IN BLOOD AND EXTRACELLULAR-SPACE OF RAT CEREBRAL-CORTEX [J].
LUCKE, A ;
MAYER, T ;
ALTRUP, U ;
LEHMENKUHLER, A ;
DUSING, R ;
SPECKMANN, EJ .
EPILEPSIA, 1994, 35 (05) :922-926
[29]  
LUX HD, 1973, EXP BRAIN RES, V17, P190
[30]  
MULLER W, 1988, EXP BRAIN RES, V72, P287